Related by context. All words. (Click for frequent words.) 69 cethromycin 68 Cethromycin 68 Anthim 68 OMAPRO 67 Archexin 67 oral prodrug 67 NEUMUNE 67 CBLB# 66 DXL# 66 Valortim 66 Protexia R 66 Ceflatonin 66 Restanza TM 65 celgosivir 65 ceftaroline 65 ruxolitinib 65 ganetespib 65 rilonacept 65 Azedra 65 talactoferrin 65 Amigal 65 forodesine 65 GATTEX TM 65 blinatumomab 64 AP# [003] 64 Icatibant 64 ofatumumab 64 Traficet EN 64 RIGScan CR 64 Golimumab 64 faropenem 64 Valortim ® 64 MAA submission 64 LibiGel ® 64 tanespimycin 64 Chemophase 64 CR# vcMMAE 64 INCB# [001] 64 oritavancin 64 vemurafenib 64 methylnaltrexone 64 L BLP# 64 JAK inhibitor 64 HuMax EGFr 64 BENLYSTA ® 63 radezolid 63 HuLuc# 63 alvespimycin 63 HCV protease inhibitor 63 PCK# 63 romidepsin 63 ATL# [001] 63 Plicera 63 OncoVEX GM CSF 63 LymphoStat B 63 IMA# 63 mapatumumab 63 GLP toxicology studies 63 CIMZIA TM 63 torezolid phosphate 63 Civacir 63 XmAb# 63 BLA filing 63 SCH # 63 obatoclax 63 PROSTVAC TM 63 HuMax CD4 63 Telavancin 63 omacetaxine 63 ALKS 63 NVA# 63 Numax 63 EndoTAG TM -1 63 BENLYSTA 63 Aplidin 63 ARIKACE 63 Serdaxin 63 Phase Ib 63 ponatinib 63 Altastaph 63 CRMD# 63 Valortim R 62 daptomycin 62 Biologic License Application BLA 62 anidulafungin 62 eniluracil 62 Vilazodone 62 trastuzumab DM1 T DM1 62 CCX# 62 torezolid 62 riociguat 62 Triolex 62 Exelixis XL# 62 Catena ® 62 registrational 62 Shigamabs ® 62 INCB# [002] 62 albinterferon alfa 2b 62 ADVEXIN 62 ELACYT 62 tezampanel 62 ThermoDox ® 62 Q#IR 62 LUVENIQ 62 Urocidin 62 sapacitabine 62 AEG# 62 HGS ETR1 62 iclaprim 62 teduglutide 62 PXD# 62 Elagolix 62 biodefense countermeasure 62 otelixizumab 62 EOquin TM 62 Fodosine 62 Mipomersen 62 BCX# 62 NovaBay Aganocide compounds 62 Protexia ® 62 YONDELIS 62 PROMACTA 62 alvimopan 62 GALNS 62 PLK1 SNALP 62 Zerenex 62 Ketotransdel 62 pralatrexate 62 ASONEP 62 NP2 Enkephalin 62 Guanilib 62 Microcyn Technology 62 Proxinium TM 62 R#/MEM # 62 BrachySil TM 62 Pixuvri 62 ZEVALIN 62 virus HCV protease inhibitor 62 phase Ib 62 AeroLEF TM 62 aclidinium 62 Virulizin ® 62 IND submission 62 favorable pharmacokinetic profile 62 Aurexis 62 Myocet 62 AVP #D# 62 immunotherapeutic vaccine 62 vilazodone 62 Xcytrin R 62 Zalbin 62 PREOS R 62 elotuzumab 62 CABP 62 tipranavir 62 Nanobody 62 Onrigin 62 BAL# [002] 62 cancer immunotherapies 62 Dalbavancin 62 TYGACIL 62 canakinumab 62 TOLAMBA 62 phase IIa clinical 61 Glybera R 61 FOLOTYN 61 PDE4 inhibitor 61 Phase Ib study 61 Hedgehog antagonist 61 Tarceva TM 61 eltrombopag 61 Plenaxis TM 61 receptor tyrosine kinase inhibitor 61 Panzem 61 pradefovir 61 Panzem R NCD 61 orBec 61 ATL/TV# 61 TBC# 61 Phase Ib II 61 HuMax CD# 61 Cloretazine 61 PEG SN# 61 oral antiviral 61 isavuconazole 61 vosaroxin 61 lumiliximab 61 Ceflatonin R 61 registrational trial 61 DORIBAX 61 atrasentan 61 IMGN# 61 Zenvia Phase III 61 maribavir 61 BEXXAR 61 Rhucin ® 61 tamibarotene 61 Evoltra ® 61 valopicitabine 61 picoplatin 61 IRX 2 61 dalbavancin 61 MGCD# [001] 61 EOquin 61 PRT# 61 ixabepilone 61 BRIM2 61 Firazyr 61 Zelrix 61 MAXY G# 61 Nanobody ® 61 perifosine 61 telaprevir VX 61 Amrubicin 61 SparVax TM 61 glufosfamide 61 Phase 1b trial 61 ILUVIEN ® 61 Surfaxin LS 61 ALN VSP 61 linaclotide 61 FOLOTYN ® 61 BLA submission 61 panitumumab 61 OHR/AVR# 61 Tarvacin TM 61 Anidulafungin 61 thymalfasin 61 CCR5 mAb 61 fidaxomicin 61 OvaRex R 61 ALN RSV# 61 Protectan CBLB# 61 Allovectin 7 61 Onrigin TM 61 ALN TTR 61 voclosporin 61 bicifadine 61 FluINsure 61 NXL# 61 Mepact 60 Voraxaze 60 ZYBRESTAT 60 TroVax 60 Carfilzomib 60 RhuDex ® 60 Marqibo 60 UPLYSO 60 Arikace 60 Alocrest 60 sunitinib malate 60 ketolide antibiotic 60 reslizumab 60 THALOMID 60 Bicifadine 60 lintuzumab 60 Panzem R 60 Alzhemed TM 60 Dacogen injection 60 Exherin TM 60 pomalidomide 60 mertansine 60 AZILECT ® 60 pexiganan 60 GRN# 60 Telaprevir 60 elvucitabine 60 Telatinib 60 Rhucin R 60 AEGR 60 investigational monoclonal antibody 60 doripenem 60 ProSavin 60 SNT MC# 60 Hematide ™ 60 dacetuzumab 60 vidofludimus 60 ZK EPO 60 forodesine hydrochloride 60 StaphVAX R 60 oral methylnaltrexone 60 tafamidis 60 Phase #b/#a 60 CEQ# 60 Azixa 60 Pirfenidone 60 vascular disrupting agent 60 Zemplar Capsules 60 PhosLo 60 OvaRex ® MAb 60 CD# monoclonal antibody 60 Phenoptin 60 Neuradiab 60 Acute Radiation Syndrome ARS 60 confirmatory Phase 3 60 PREOS 60 Trofex 60 apricitabine ATC 60 oral ridaforolimus 60 ozarelix 60 Chimigen TM 60 AzaSite Plus 60 Alvesco R 60 StaphVAX 60 regorafenib 60 Ceftobiprole 60 enzastaurin 60 motexafin gadolinium Injection 60 HepeX B 60 Zenvia ™ 60 Sym# 60 PSMA ADC 60 Symadex 60 SEBIVO 60 Phase 1b 60 Romidepsin 60 BiTE antibody 60 Orphan Drug designations 60 Tyrima 60 amrubicin 60 AEOL # 60 Phase 2a trial 60 ZEVALIN ® 60 nitazoxanide 60 Phase 2b trial 60 Cinryze TM 60 baminercept 60 Unit Dose Budesonide 60 custirsen 60 rPA anthrax vaccine 60 Reolysin 60 MAXY alpha 60 OXi# 60 Rhucin 60 Tamibarotene 60 investigational humanized monoclonal antibody 60 Nexavar ® 60 AZILECT R 60 Spiegelmer ® 60 Simulect 60 brentuximab vedotin SGN 60 cystinosis patients 60 ATryn R 60 pafuramidine 60 rALLy trial 59 casopitant 59 Actemra tocilizumab 59 RAPAFLO 59 phase IIb clinical 59 KNS # 59 BEMA TM Fentanyl 59 HQK 59 CoFactor 59 Zingo TM 59 Zoraxel 59 Cetrorelix 59 Radezolid 59 Onconase 59 phase IIb trial 59 Evoltra 59 MEK inhibitor RDEA# 59 Homspera 59 atacicept 59 S/GSK# 59 deforolimus 59 CD# CEA 59 Xanafide 59 TKM Ebola 59 delafloxacin 59 Dificid 59 OncoVEX 59 Removab 59 Onco TCS 59 zileuton CR 59 Folotyn 59 velafermin 59 Clolar ® 59 mifamurtide 59 Phase #/#a 59 DAVANAT R 59 cutaneous T cell 59 huC# DM4 59 TRANSDUR Bupivacaine 59 SinuNase 59 HGS ETR2 59 biodefense pathogens 59 Ramoplanin 59 compound INCB# 59 Blinatumomab 59 voreloxin 59 talabostat 59 Phase IIb clinical trials 59 KYNAPID 59 Teflaro 59 GAP #B# 59 OncoVex 59 Biologics License Application 59 R#/MEM 59 phase IIa 59 MEPACT 59 CIMZIA ™ 59 Trofex TM 59 ATryn ® 59 Phase III HEAT 59 Elesclomol 59 BAY #-# 59 MAGE A3 ASCI 59 SinuNase TM 59 BiovaxID 59 leading oral taxane 59 lomitapide 59 cariprazine 59 DPX Survivac 59 CONBRIZA 59 IMVAMUNE R 59 Pazopanib 59 Cellegesic 59 LymphoStat B belimumab 59 ospemifene 59 glucokinase activator 59 tesetaxel 59 NPSP# 59 Phase 2b Clinical Trial 59 SURFAXIN 59 Fast Track Status 59 PrevOnco ™ 59 oral taxane 59 liprotamase 59 L MTP PE 59 HDAC Inhibitor 59 NEBIDO 59 peginesatide 59 Perifosine 59 Mycograb 59 Tarmogen 59 CBLC# 59 Zebinix R 59 Phase Ib clinical 59 Phase 2a 59 pharmacokinetic PK study 59 HspE7 59 PNP inhibitor 59 ONGLYZA ™ 59 brivaracetam 59 Ceflatonin ® 59 ezogabine 59 CINQUIL 59 Vandetanib 59 therapeutic monoclonal antibodies 59 Bezielle 59 Orphan Status 59 RPL# 59 Factor VIIa 59 Cloretazine R VNP#M 59 GSK# [001] 59 RGB # 59 TMC# [002] 59 immunosuppressant therapies 59 Medical Countermeasure 59 Gleevec imatinib mesylate 59 Fibrin Pad 59 omacetaxine mepesuccinate 59 Cardio Vascu Grow 59 Menerba 59 anticancer compound 59 Insegia 59 Pimavanserin 59 TYZEKA 59 Mpex 59 therapeutic monoclonal antibody 59 Troxatyl 59 MabCampath 59 Tesetaxel 59 PHX# 59 orphan designation 59 daclizumab 59 Urocidin TM 59 anthrax monoclonal antibody 59 Excellarate 59 MGN# 59 Noxafil 59 GLPG# 59 ENMD # 59 SUTENT ® 59 Japanese Encephalitis vaccine 59 Prochymal 59 MDV# 59 OraTest 59 Marketing Authorisation Application 59 Lenocta 59 Diamyd ® 59 Mycamine 59 BARACLUDE R 59 MyVax R 59 Zolinza 59 CCX# B 59 Fx #A 59 Benlysta belimumab 59 acyclovir Lauriad R 59 TRO# 59 FDA Orphan Drug 59 zanolimumab 59 oral FTY# 59 LymphoStat B TM 59 Locteron 59 BRIM3 59 ganaxolone 59 ISTODAX 59 Delcath PHP System 59 rNAPc2 58 RSR# 58 Nabi HB Intravenous 58 Junovan 58 antibiotic resistant bacterial infections 58 sorafenib tablets 58 Neurodex 58 DIFICID 58 Cloretazine ® 58 PSN# [002] 58 MEK inhibitor 58 lucinactant 58 Phase 2b study 58 Febuxostat 58 ASA# 58 CCR5 antagonist 58 MoxDuo IR 58 tivozanib 58 Bronchitol 58 TACI Ig 58 Aryplase 58 Initiates Clinical 58 Marketing Authorization Application 58 Voraxaze ™ 58 ALN PCS 58 Behcet uveitis 58 SUTENT 58 Bioral Amphotericin B 58 Pivotal Phase III 58 evaluating tivozanib 58 Corlux 58 JOULFERON 58 RG# [001] 58 T Pred 58 Tygacil 58 StemEx R 58 compound AEOL # 58 alefacept 58 Onalta ™ 58 QNEXA 58 Alferon N 58 TPI ASM8 58 ACTEMRA TM 58 Shigamabs R 58 oral Xeloda 58 URG# 58 CCR9 antagonist 58 huN# DM1 58 highly selective adenosine 58 OMP #R# 58 investigational compound 58 Epratuzumab 58 tocilizumab 58 apricitabine 58 vismodegib 58 ThermoDox R 58 Omapro 58 ACZ# 58 herpetic keratitis 58 Pafuramidine 58 RNAi therapeutic 58 Stimuvax R 58 Phase IIa clinical 58 indolent NHL 58 Meets Primary Endpoint 58 Vicriviroc 58 OMNARIS HFA 58 indacaterol 58 orphan medicinal product 58 Ceplene 58 oral salmon calcitonin 58 CYT# 58 BrachySil 58 EP #R 58 Hedgehog Pathway Inhibitor 58 CORT # 58 rALLy clinical trial 58 Phase III Clinical Trial 58 Rasagiline 58 DR Cysteamine 58 Iluvien ® 58 Velcade bortezomib 58 MyVax 58 Rezular 58 davunetide intranasal AL 58 ONCONASE 58 FavId 58 GATTEX ® 58 Bortezomib 58 Campath ® 58 Indaflex TM 58 Dyloject TM 58 SUCCEED trial 58 GAMMAGARD 58 lymphoma CTCL 58 TOCOSOL Paclitaxel 58 RIGScan 58 prGCD 58 preclinically 58 belinostat 58 Aclidinium 58 Capesaris 58 HCV Protease Inhibitor 58 MabThera rituximab 58 Onalta 58 Azedra TM 58 Phase IIB 58 balsalazide tablet 58 elacytarabine 58 zalutumumab 58 Loramyc R 58 tezampanel NGX# 58 nosocomial pneumonia 58 Laquinimod 58 CG# [003] 58 Revimmune 58 Naproxcinod 58 DAVANAT 58 aclidinium bromide 58 ACHN 58 IAP inhibitors 58 polymerase inhibitors 58 Aerosurf 58 tesmilifene 58 Tavocept 58 Dendreon Provenge 58 docetaxel Taxotere R 58 Androxal ® 58 ustekinumab 58 HCV polymerase 58 PEG Interferon lambda 58 Certican 58 refractory chronic lymphocytic 58 HCD# [002] 58 Prestara 58 investigational protease inhibitor 58 ThermoDox 58 BRAF inhibitor 58 Octreolin 58 Phase III Clinical Trials 58 Doribax 58 phase IIb 58 Bazedoxifene 58 autologous cellular immunotherapy 58 PANVAC VF 58 RANK Ligand inhibitor 58 galiximab 58 BENLYSTA TM 58 TYKERB 58 LEUKINE 58 Telbivudine 58 Anturol TM 58 ARIKACE ™ 58 TORISEL 58 axitinib 58 CMV vaccine 58 OMP designation 58 Ofatumumab 58 PI3K/Akt pathway inhibitor 58 Phase III Pivotal 58 Phase III pivotal 58 bortezomib Velcade R 58 SAR# [004] 58 preclinical efficacy 58 H#N# VLP vaccine 58 Fidaxomicin 58 abiraterone acetate 58 M Enoxaparin 58 MOZOBIL 58 Allovectin 7 R 58 #D#C# 58 solithromycin 58 PRTX 58 YERVOY 58 HCV protease inhibitors 58 Arimoclomol 58 TransVax ™ 58 rALLy 58 APTIVUS 58 ongoing Phase 1b 58 Prodarsan ® 58 multi kinase inhibitor 58 confirmatory Phase III 58 Aptivus 58 ON #.Na 58 RAPTIVA 58 Phase 2b 58 iSONEP 58 Talabostat 58 hematological cancers 58 NDA submission 58 Clevudine 58 NOX E# 58 influenza VLP vaccine 58 raxibacumab 58 relapsed multiple myeloma 58 PROVENGE ® 58 thetreatment 58 TG# [003] 58 denufosol 58 Ozarelix 58 targeted radiotherapeutic 58 RiVax 58 Debio 58 Nuvion 58 midstage trials 58 RDEA# 58 GATTEX 58 BLP# Liposome Vaccine 58 rhThrombin 58 Omigard 58 Lovaxin C 58 cilengitide 58 PrevOnco 57 ELIQUIS 57 APOPTONE 57 Evoltra TM 57 Alpharadin 57 Virulizin 57 SNT-MC#/idebenone 57 oxypurinol 57 Genentech Roche 57 Phase IIb Clinical Trial 57 Ostabolin C 57 Phase III psoriasis 57 Synavive 57 Onbrez Breezhaler 57 XL# [003] 57 investigational therapies 57 systemic RNAi therapeutic 57 nilotinib 57 Relivar 57 fosbretabulin 57 Cimzia ® 57 Hycamtin 57 BNC# 57 Oglemilast 57 Fablyn 57 CAMPATH 57 Biologics License Application BLA 57 Glufosfamide 57 Clolar 57 posaconazole 57 NOXAFIL 57 KIACTA ™ 57 cell lymphoma CTCL 57 Atiprimod 57 ELND# 57 Maribavir 57 TREANDA 57 Avastin bevacizumab 57 Annamycin 57 generation URAT1 inhibitor 57 Vion Pharmaceuticals 57 paclitaxel poliglumex 57 phase IIb study 57 Kynapid 57 darusentan 57 NEUGENE 57 ORENCIA R 57 severe hypercholesterolemia 57 tecarfarin 57 FIRMAGON R 57 refractory gout 57 Prostate AdenoCarcinoma Treatment 57 ZFP Therapeutic 57 Ambrisentan 57 Cinryze ™ 57 refractory APL 57 BAL# [001] 57 antibody MAb 57 Diabetic Macular Edema 57 QAB# 57 epigenetic therapies 57 GTC recombinant human 57 velaglucerase alfa 57 selective androgen receptor modulator 57 JAK Inhibitor 57 mitogen activated ERK kinase 57 miconazole Lauriad ® 57 mipomersen 57 crofelemer 57 Phase IIb 57 HuCAL antibodies 57 Phase III TRIST 57 apremilast 57 Fibrillex TM 57 Albuferon 57 Jevtana 57 GATTEX ™ 57 tipifarnib 57 intranasal formulation 57 omega interferon 57 dextromethorphan quinidine 57 pDNA vaccine 57 KRN# 57 Phase III 57 Thiovir 57 TARIS 57 elagolix 57 faropenem medoxomil 57 Torisel 57 ambrisentan 57 Nebido 57 PolyActive ® 57 Files Investigational 57 ocrelizumab 57 ridaforolimus 57 TRAIL receptor antibodies 57 Arcalyst 57 Abiraterone acetate 57 Phase 2b clinical 57 YONDELIS R 57 PS# [001] 57 oral RELISTOR 57 Huntexil 57 Safinamide 57 Acetavance 57 OFIRMEV 57 histone deacetylase HDAC inhibitor 57 Phase IIIb clinical 57 FDA Approvable Letter 57 Dr. McHutchison 57 Poly ICR 57 bardoxolone 57 Gattex 57 Ebola SNALP 57 MyVax personalized immunotherapy 57 Successfully Completes Phase 57 Romiplostim 57 pemetrexed Alimta 57 Phase IIa trial 57 Stedivaze 57 Vitaxin 57 ZADAXIN ® 57 PEG interferon 57 AAG geldanamycin analog 57 INT# [002] 57 FACTIVE 57 davunetide 57 ATPace TM 57 Pivotal Phase 57 integrase inhibitor 57 Ferumoxytol 57 pegylated interferon alpha 57 OMP #M# 57 plasma kallikrein inhibitor 57 pegylated interferons 57 BiovaxID TM 57 VitiGam TM 57 Oritavancin 57 Personalized Immunotherapy 57 Phase #b/#a clinical 57 IRESSA 57 ularitide 57 MT#/MEDI-# 57 LHRH antagonist 57 acetonide FA 57 JAK inhibitors 57 Toraymyxin TM 57 ALGRX 57 BRAF V# mutation 57 Daclizumab 57 Dasatinib 57 PROCHYMAL 57 radiation sensitizer 57 PhG alpha 1 57 VitiGam 57 Saforis 57 Gamunex C 57 JAK2 inhibitor 57 OMS#HP 57 pediatric acute lymphoblastic 57 Tarvacin 57 cSSSI 57 Ustekinumab 57 SILENOR 57 Nanobody R 57 Ophena TM 57 Aflibercept 57 GFT# 57 Zalypsis 57 HEPLISAV TM 57 Belimumab 57 Viramidine 57 SYCREST 57 docetaxel Taxotere ® 57 Omacetaxine 57 Vibativ 57 tiapamil 57 Arranon 57 XL# XL# 57 CIP TRAMADOL ER 57 maximally tolerated dose 57 ADVEXIN clinical 57 non nucleoside inhibitor 57 DexaSite 57 neratinib 57 Santhera 57 ataluren 57 Phase #/#a trial 57 ApoB SNALP 57 pivotal Phase III 57 nanoviricides 57 crizotinib PF # 57 Pivotal Study 57 AEZS 57 ALN TTR# 57 gastrointestinal stromal tumors GIST 57 abatacept Orencia 57 RECOTHROM R 57 Tovaxin 57 PF # [001] 57 Azilect ® 57 histamine dihydrochloride 57 Orphan Drug designation 57 BCR ABL inhibitor 57 Solorel 57 Satraplatin 57 XYOTAX TM 57 SinuNase ™ 57 IV acetaminophen 57 LEVADEX ™ 57 anticancer agent 57 Ostarine 57 Medidur FA 57 CDP# 57 Firdapse 57 Zenvia TM 57 Virulizin R 57 Exelon Patch 57 ZADAXIN 57 SPRYCEL ® 57 liposomal ciprofloxacin 57 Nexavar sorafenib 57 Difimicin 57 motesanib 57 edoxaban 57 CYT# potent vascular disrupting 57 HGS# 57 Esbriet ® 57 MGd 57 LHRH antagonists 57 ENMD 57 phase 2a 57 lorvotuzumab mertansine 57 Actilon 57 Oracea TM 57 Curaxin CBLC# 57 Juvaris 57 Alnylam #x# 57 successfully commercialize Iluvien 57 Neugene 57 ONGLYZA 57 HEPLISAV 57 next generation URAT1 57 Davanat 57 Androxal 57 Pralatrexate 57 TAFA# 57 EVIZON 57 Nasulin 57 supplemental Biologics License Application 57 Targretin 57 Veronate 57 protein kinase inhibitor 57 Vernakalant 57 Complete Response 57 PEG PAL 57 TELINTRA 57 Xinlay 57 ProLindac 57 relapsed refractory multiple myeloma 57 budesonide foam 57 imetelstat 57 PROVENGE sipuleucel T 57 Triapine 57 Orazol 57 Relovair 57 Phase 1a clinical 57 StemEx 57 indibulin 57 Quinamed 56 Troxatyl TM 56 Tasimelteon 56 relapsed MM 56 ONCONASE R 56 FluCide 56 Gleevec Glivec 56 Hepatitis C HCV